RecruitingPhase 4NCT05783661

Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY)

Randomized Controlled Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis


Sponsor

Eva Bonfill

Enrollment

198 participants

Start Date

Dec 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Study to comparing conventrional antibiotic strategies versus regimens guided by epidemiological surveillance in infected patients with cirrhosis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Conventional antibiotic strategies and Regimens guided by epidemiological surveillance for people with bacterial infections and decompensated cirrhosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERConventional antibiotic strategies

Treatment according to the local guidelines of the Hospital Clinic de Barcelona.

OTHERRegimens guided by epidemiological surveillance

Treatment according to the local guidelines of the Hospital Clinic de Barcelona guided by colonization/epidemiological surveillance.


Locations(1)

Eva Bonfill

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05783661


Related Trials